Close Menu

NEW YORK – 10x Genomics has countersued Bio-Rad Laboratories in a US District Court patent infringement suit.

Last week, 10x responded to Bio-Rad's allegations that 10x's Next GEM microfluidic chips infringe US Patent No. 10,190,115, "Methods and compositions for nucleic acid analysis" which covers the partitioning of a sample into droplets, in some cases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.